Brookline, MA, United States of America

Sungwhan Oh

This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Harvard College, The Brigham and Women's Hospital, Inc.. Active years: 2019-2022.

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Location History:

  • Brookline, MA (US) (2019 - 2020)
  • Cambridge, MA (US) (2022)

Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Sungwhan Oh

Introduction

Sungwhan Oh is a notable inventor based in Brookline, MA, who has made significant contributions to the field of immunology. With a total of three patents to his name, he has focused on developing innovative compositions and methods that enhance immune responses.

Latest Patents

One of his latest patents is titled "Glycolipid compositions and methods of use." This invention provides immunostimulatory glycolipids and compositions thereof, along with methods of use. Another significant patent is "Lipidated PSA compositions and methods," which offers various isolated and synthetic forms of lipidated PSA, as well as methods for isolating these forms and their applications.

Career Highlights

Sungwhan Oh has worked with prestigious institutions such as Harvard College and Brigham and Women's Hospital, Inc. His work in these organizations has allowed him to contribute to groundbreaking research and development in his field.

Collaborations

He has collaborated with esteemed colleagues, including Dennis L. Kasper and Deniz Erturk-Hasdemir, further enhancing the impact of his research and inventions.

Conclusion

Sungwhan Oh's innovative work in immunology, particularly through his patents, showcases his commitment to advancing medical science. His contributions are valuable to the ongoing research in immunostimulatory therapies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…